ArticleFrontiers in neurology2025

Nusinersen for children with type I spinal muscular atrophy: 4 years' clinical experience in Turkish cohort.

Ömer Bektaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.